Are you diagnosed with MSA (Multiple System Atrophy)

[wobblybee]

MSA trial into dizziness relief treatment seeks participants

Do you suffer from dizziness, light-headedness and feeling faint? The SEQUOIA Study is a clinical research study looking at an investigational drug called ampreloxitine (also known as TD-9855), for people with Multiple System Atrophy (MSA). Upon standing, some people with MSA experience dizziness, light-headedness, feeling faint, or feeling like they might black out due to a drop in blood pressure. Researchers want to learn whether ampreloxitine can reduce these symptoms and assess how safe it is. If you have MSA, suffer from symptoms such as these and are 30 years of age or older you may be able to take part. Study sites are currently open in London, Exeter, Plymouth and Birmingham. For more information, view the MSA Trust website.